These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31803968)

  • 21. Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response.
    Witkiewitz K; Roos CR; Mann K; Kranzler HR
    Alcohol Clin Exp Res; 2019 Nov; 43(11):2395-2405. PubMed ID: 31436886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of alcohol use disorder treatments: an update.
    Hartwell EE; Kranzler HR
    Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):553-564. PubMed ID: 31162983
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging drugs to treat alcoholism.
    Soyka M; Rösner S
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):695-711. PubMed ID: 20560783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
    Helton SG; Lohoff FW
    Psychiatry Res; 2015 Dec; 230(2):121-9. PubMed ID: 26455758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 26. A translational approach to novel medication development for protracted abstinence.
    Mason BJ; Higley AE
    Curr Top Behav Neurosci; 2013; 13():647-70. PubMed ID: 22351425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 40th anniversary of the National Institute on Alcoholism and Alcohol Abuse: the impact on liver disease.
    Szabo G
    Hepatology; 2010 Jul; 52(1):10-2. PubMed ID: 20578124
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenomics and personalized medicine in clinical practice.
    Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
    Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medications and alcohol craving.
    Swift RM
    Alcohol Res Health; 1999; 23(3):207-13. PubMed ID: 10890816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy of alcohol use disorders.
    Buonopane A; Petrakis IL
    Subst Use Misuse; 2005; 40(13-14):2001-20, 2043-8. PubMed ID: 16282090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of medications in the manaqement of alcohol dependence.
    Prescrire Int; 2013 Sep; 22(141):217. PubMed ID: 24171219
    [No Abstract]   [Full Text] [Related]  

  • 33. Medications development for alcohol use disorders.
    Wright C
    Psychopharmacol Bull; 1995; 31(4):681-6. PubMed ID: 8851640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for alcohol dependence.
    West SL; Garbutt JC; Carey TS; Lux LJ; Jackman AM; Tolleson-Rinehart S; Lohr KN; Crews FT
    Evid Rep Technol Assess (Summ); 1999 Jan; (3):1-5. PubMed ID: 11487800
    [No Abstract]   [Full Text] [Related]  

  • 36. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.
    Yardley MM; Ray LA
    Addict Biol; 2017 May; 22(3):581-615. PubMed ID: 26833803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological control of alcohol consumption: tactics for the identification and testing of new drugs.
    Naranjo CA; Cappell H; Sellers EM
    Addict Behav; 1981; 6(3):261-9. PubMed ID: 7027758
    [No Abstract]   [Full Text] [Related]  

  • 38. Research refines alcoholism treatment options.
    Alcohol Res Health; 2000; 24(1):53-61. PubMed ID: 11199275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's in a name? Proposed name changes of the US National Institute on Drug Abuse and the US National Institute on Alcohol Abuse and Alcoholism.
    Midanik LT
    Addiction; 2008 Jan; 103(1):1-3. PubMed ID: 18081607
    [No Abstract]   [Full Text] [Related]  

  • 40. Interactions Between the U.S. National Institute on Alcohol Abuse and Alcoholism and the Alcohol Industry: Evidence From Email Correspondence 2013-2020.
    Mitchell G; McCambridge J
    J Stud Alcohol Drugs; 2023 Jan; 84(1):11-26. PubMed ID: 36799670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.